Skip to content
TrialScanner

NCT05188729

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

Phase 2CompletedVRCALead

Registry record

Lead sponsor
Verrica Pharmaceuticals Inc.
Conditions
Basal Cell Carcinoma; Skin Cancer; Cancer of the Skin, Basal Cell; Cancer of the Skin; Carcinoma
Primary completion
Apr 15, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05188729 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05188729: Open-Label Proof of Concept... | TrialScanner